Top Markets
Coin of the day
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Rang în acțiuni #17309
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Preț acțiune
$1.21
Capitalizare de piață
$248.41M
Schimbare (1 zi)
4.11%
Schimbare (1 an)
79.12%
Țară
TW
Tranzacționează TWi Biotechnology, Inc. (6610)

Categorie

Istoric al prețului acțiunii pentru TWi Biotechnology, Inc. (6610)
Cel mai mare preț de închidere: $1.18 pe 2026-09-01

Cel mai mic preț de închidere: $1.95 pe 2016-12-01
Istoric al prețului acțiunii pentru TWi Biotechnology, Inc. din 2016 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 43.11%
2025 36.47%
2024 -13.49%
2023 13.07%
2022 -19.33%
2021 0.82%
2020 81.49%
2019 -54.47%
2018 -43.81%
2017 -42.56%
2016 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$553.73 38.09%
US
$1.05K 47.97%
NL
$148.19 512.61%
US
$122.21 -10.03%
AU
$757.71 8.20%
CH